Evidence map›Paper›PMID 34269117›Full record

ReviewThe Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry2022

The Interplay between Chronic Pain, Opioids, and the Immune System.

Valentina Malafoglia, Sara Ilari, Laura Vitiello, Michael Tenti, Eleonora Balzani, Carolina Muscoli, William Raffaeli, Antonello Bonci

Open access · hybridAbstract readReview
In one paragraph

Review in The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Opioid usage and COVID-19 prognosis: A systematic review and meta-analysis.The American journal of emergency medicine · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Valentina MalafogliaInstitute for Research on Pain, ISAL Foundation, Rimini, Italy.ORCID 0000-0002-1533-704X
Sara IlariDepartment of Health Science Institute of Research for Food Safety & Health (IRC-FSH), University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Laura VitielloFlow Cytometry Unit, IRCCS San Raffaele, Rome, Italy.
Michael TentiInstitute for Research on Pain, ISAL Foundation, Rimini, Italy.
Eleonora BalzaniDepartment of Surgical Science, University of Turin, Turin, Italy.
Carolina MuscoliDepartment of Health Science Institute of Research for Food Safety & Health (IRC-FSH), University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
William RaffaeliInstitute for Research on Pain, ISAL Foundation, Rimini, Italy.
Antonello BonciGlobal Institute on Addictions, Miami, FL, USA.
Fondazione ISAL · ITMagna Graecia University · ITGlobal Institutes on Addictions · USIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic pain represents one of the most serious worldwide medical problems, in terms of both social and economic costs, often causing severe and intractable physical and psychological suffering. The lack of biological markers for pain, which could assist in forming clearer diagnoses and prognoses, makes chronic pain therapy particularly arduous and sometimes harmful. Opioids are used worldwide to treat chronic pain conditions, but there is still an ambiguous and inadequate understanding about their therapeutic use, mostly because of their dual effect in acutely reducing pain and inducing, at the same time, tolerance, dependence, and a risk for opioid use disorder. In addition, clinical studies suggest that opioid treatment can be associated with a high risk of immune suppression and the development of inflammatory events, worsening the chronic pain status itself. While opioid peptides and receptors are expressed in both central and peripheral nervous cells, immune cells, and tissues, the role of opioids and their receptors, when and why they are activated endogenously and what their exact role is in chronic pain pathways is still poorly understood. Thus, in this review we aim to highlight the interplay between pain and immune system, focusing on opioids and their receptors.

Indexed as

Analgesics, OpioidChronic PainHumansImmune SystemAnalgesics, Opioidchronic painchronic pain biomarkerschronic pain diagnosisimmune cellsimmune systemneuroimmune synapseopioid receptorsopioid receptor signalling pathwayopioidspain

Identifiers

PMID34269117
PMCPMC9647319
OpenAlexW3182684351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.